Financial Ratios Medacta Group SA
Equities
MOVE
CH0468525222
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.00 CHF | -1.26% | +1.29% | +3.19% |
Sep. 25 | Swiss Market Index Advances Ahead of SNB's Rate Decision Day | MT |
Sep. 25 | Medacta Group SA - Analyst/Investor Day |
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
Return on Assets | 6.92 | 7.73 | 9.13 | 8.09 | 7.47 | |||
Return on Total Capital | 10.17 | 11.17 | 12.56 | 10.74 | 9.75 | |||
Return On Equity % | 11.17 | 25.76 | 26.35 | 18.46 | 15.66 | |||
Return on Common Equity | 11.17 | 25.76 | 26.35 | 18.46 | 15.66 | |||
Margin Analysis | ||||||||
Gross Profit Margin % | 72.02 | 70.83 | 71.94 | 69.83 | 68.1 | |||
SG&A Margin | 55.89 | 51.33 | 50.53 | 50.38 | 49.43 | |||
EBITDA Margin % | 22.37 | 27.09 | 27.18 | 24.47 | 23.42 | |||
EBITA Margin % | 14.9 | 18.56 | 19.58 | 16.63 | 15.61 | |||
EBIT Margin % | 13.87 | 17.47 | 18.72 | 15.89 | 14.98 | |||
Income From Continuing Operations Margin % | 3.82 | 12.26 | 14.19 | 10.58 | 9.27 | |||
Net Income Margin % | 3.82 | 12.26 | 14.19 | 10.58 | 9.27 | |||
Net Avail. For Common Margin % | 3.82 | 12.26 | 14.19 | 10.58 | 9.27 | |||
Normalized Net Income Margin | 7.47 | 8.95 | 11.13 | 8.98 | 7.44 | |||
Levered Free Cash Flow Margin | -2.67 | 8.98 | -5.09 | -1.78 | -6.88 | |||
Unlevered Free Cash Flow Margin | -2 | 9.61 | -4.5 | -1.25 | -6.04 | |||
Asset Turnover | ||||||||
Asset Turnover | 0.8 | 0.71 | 0.78 | 0.81 | 0.8 | |||
Fixed Assets Turnover | 2.14 | 1.95 | 2.18 | 2.2 | 2.1 | |||
Receivables Turnover (Average Receivables) | 6.74 | 6.45 | 6.9 | 6.36 | 5.92 | |||
Inventory Turnover (Average Inventory) | 0.91 | 0.82 | 0.81 | 0.89 | 0.87 | |||
Short Term Liquidity | ||||||||
Current Ratio | 1.56 | 1.5 | 1.67 | 3.18 | 2.33 | |||
Quick Ratio | 0.69 | 0.69 | 0.64 | 1.32 | 0.82 | |||
Operating Cash Flow to Current Liabilities | 0.35 | 0.41 | 0.4 | 0.83 | 0.5 | |||
Days Sales Outstanding (Average Receivables) | 54.14 | 56.77 | 52.88 | 57.36 | 61.67 | |||
Days Outstanding Inventory (Average Inventory) | 400.71 | 447.61 | 448.33 | 410.2 | 419.17 | |||
Average Days Payable Outstanding | 69.63 | 62.32 | 62.55 | 63.65 | 56.74 | |||
Cash Conversion Cycle (Average Days) | 385.22 | 442.06 | 438.66 | 403.92 | 424.1 | |||
Long Term Solvency | ||||||||
Total Debt/Equity | 124.04 | 91.32 | 59.73 | 62.78 | 61.74 | |||
Total Debt / Total Capital | 55.36 | 47.73 | 37.39 | 38.57 | 38.17 | |||
LT Debt/Equity | 81.08 | 47.77 | 28.72 | 57.88 | 44.91 | |||
Long-Term Debt / Total Capital | 36.19 | 24.97 | 17.98 | 35.56 | 27.77 | |||
Total Liabilities / Total Assets | 70.13 | 62.73 | 53.73 | 53.01 | 52.57 | |||
EBIT / Interest Expense | 12.83 | 17.36 | 19.75 | 18.96 | 11.2 | |||
EBITDA / Interest Expense | 21.99 | 28.46 | 30 | 30.74 | 18.5 | |||
(EBITDA - Capex) / Interest Expense | 9.64 | 19.5 | 16.49 | 14.79 | 8.3 | |||
Total Debt / EBITDA | 2.07 | 1.74 | 1.31 | 1.53 | 1.61 | |||
Net Debt / EBITDA | 1.7 | 1.18 | 1.11 | 1.24 | 1.45 | |||
Total Debt / (EBITDA - Capex) | 4.72 | 2.53 | 2.38 | 3.18 | 3.59 | |||
Net Debt / (EBITDA - Capex) | 3.88 | 1.72 | 2.02 | 2.59 | 3.23 | |||
Growth Over Prior Year | ||||||||
Total Revenues, 1 Yr. Growth % | 13.94 | -2.62 | 20.04 | 20.38 | 16.85 | |||
Gross Profit, 1 Yr. Growth % | 9.67 | -4.22 | 21.93 | 16.85 | 13.95 | |||
EBITDA, 1 Yr. Growth % | -17.97 | 23.24 | 20.45 | 9.35 | 11.86 | |||
EBITA, 1 Yr. Growth % | -28.21 | 29.7 | 26.66 | 3.52 | 9.68 | |||
EBIT, 1 Yr. Growth % | -30.16 | 31.79 | 28.65 | 3.54 | 10.16 | |||
Earnings From Cont. Operations, 1 Yr. Growth % | -74.08 | 212.77 | 38.9 | -10.23 | 2.41 | |||
Net Income, 1 Yr. Growth % | -74.08 | 212.77 | 38.9 | -10.23 | 2.41 | |||
Normalized Net Income, 1 Yr. Growth % | -36.27 | 27.02 | 49.21 | -1.52 | -3.17 | |||
Diluted EPS Before Extra, 1 Yr. Growth % | -74.08 | 212.77 | 39.27 | -10.34 | 2.6 | |||
Accounts Receivable, 1 Yr. Growth % | 8.97 | -4.72 | 29.82 | 31.16 | 21.41 | |||
Inventory, 1 Yr. Growth % | 13.9 | 12.35 | 19.18 | 17.79 | 33.45 | |||
Net Property, Plant and Equip., 1 Yr. Growth % | 18.47 | -2.6 | 17.2 | 21.56 | 22.35 | |||
Total Assets, 1 Yr. Growth % | 12.85 | 7.12 | 10.71 | 19.46 | 19.06 | |||
Tangible Book Value, 1 Yr. Growth % | 50.06 | 40.88 | 42.27 | 23.75 | 21.61 | |||
Common Equity, 1 Yr. Growth % | 38.36 | 33.66 | 37.45 | 21.32 | 20.16 | |||
Cash From Operations, 1 Yr. Growth % | -35.8 | 39.77 | -9.28 | 35.98 | 2.2 | |||
Capital Expenditures, 1 Yr. Growth % | -8.15 | -34.21 | 70.39 | 25.63 | 19.26 | |||